Cost-ineffectiveness of serum vancomycin levels
Eur J Clin Microbiol Infect Dis
.
2007 Jul;26(7):509-11.
doi: 10.1007/s10096-007-0314-4.
Authors
B A Cunha
1
,
S S Mohan
,
N Hamid
,
B P McDermott
,
P Daniels
Affiliation
1
Infectious Disease Division, Winthrop-University Hospital, Mineola, NY 11501, USA. llusardi@winthrop.org
PMID:
17534676
DOI:
10.1007/s10096-007-0314-4
No abstract available
MeSH terms
Cost-Benefit Analysis
Creatinine / blood
Drug Monitoring / economics*
Hospitals, University
Humans
Retrospective Studies
Vancomycin / blood*
Substances
Vancomycin
Creatinine